- Company Overview for NUGERONTIX LIMITED (06136155)
- Filing history for NUGERONTIX LIMITED (06136155)
- People for NUGERONTIX LIMITED (06136155)
- More for NUGERONTIX LIMITED (06136155)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
13 Mar 2024 | CS01 | Confirmation statement made on 5 March 2024 with updates | |
04 Mar 2024 | PSC01 | Notification of Christian Angermayer as a person with significant control on 29 November 2021 | |
04 Mar 2024 | PSC04 | Change of details for Mr Roger Corder as a person with significant control on 29 November 2021 | |
04 Mar 2024 | PSC01 | Notification of James Peyer as a person with significant control on 29 November 2021 | |
04 Mar 2024 | PSC07 | Cessation of Cambrian Biopharma Inc as a person with significant control on 29 November 2021 | |
04 Mar 2024 | PSC04 | Change of details for Mr Roger Corder as a person with significant control on 1 March 2024 | |
04 Mar 2024 | CH01 | Director's details changed for Professor Roger Corder on 1 March 2024 | |
04 Mar 2024 | CH01 | Director's details changed for Mr Kevin George Bilyard on 1 March 2024 | |
10 Jan 2024 | TM01 | Termination of appointment of Georg Christian Terstappen as a director on 18 December 2023 | |
20 Dec 2023 | AA | Total exemption full accounts made up to 30 September 2023 | |
20 Mar 2023 | AA | Total exemption full accounts made up to 30 September 2022 | |
15 Mar 2023 | CS01 | Confirmation statement made on 5 March 2023 with updates | |
14 Mar 2023 | CH01 | Director's details changed for Professor Roger Corder on 14 March 2023 | |
14 Mar 2023 | CH01 | Director's details changed for Mr Kevin George Bilyard on 14 March 2023 | |
08 Mar 2022 | CS01 | Confirmation statement made on 5 March 2022 with updates | |
17 Jan 2022 | AA | Total exemption full accounts made up to 30 September 2021 | |
14 Dec 2021 | SH01 |
Statement of capital following an allotment of shares on 29 November 2021
|
|
14 Dec 2021 | PSC02 | Notification of Cambrian Biopharma Inc as a person with significant control on 29 November 2021 | |
14 Dec 2021 | PSC04 | Change of details for Mr Roger Corder as a person with significant control on 29 November 2021 | |
08 Apr 2021 | AA | Total exemption full accounts made up to 30 September 2020 | |
11 Mar 2021 | CS01 | Confirmation statement made on 5 March 2021 with updates | |
11 Mar 2021 | PSC04 | Change of details for Mr Roger Corder as a person with significant control on 8 July 2020 | |
14 Dec 2020 | AP01 | Appointment of Mr James Peyer as a director on 2 November 2020 | |
22 Sep 2020 | TM01 | Termination of appointment of Philip Sebastian Aguiar Brunemeier as a director on 16 September 2020 | |
13 Aug 2020 | RESOLUTIONS |
Resolutions
|